Vascular Graft Market Size, Share, Growth, and Industry Analysis, By Types (ePTFE Vascular Graft, Polyester Vascular Graft, PTFE Vascular Graft, Others), By Applications (Cardiovascular Diseases, Aneurysm, Vascular Occlusion, Others) , and Regional Insights and Forecast to 2035

Vascular Graft Market Size

The Global Vascular Graft Market size reached USD 1.16 billion in 2025 and is projected to rise to USD 1.21 billion in 2026, USD 1.26 billion in 2027, and further expand to USD 1.75 billion by 2035, exhibiting a 4.2% growth rate during 2026–2035. Rising cardiovascular disease prevalence and more than 30% growth in minimally invasive procedures are accelerating demand. Increased adoption of advanced graft materials, preferred by over 40% of surgeons, is strengthening market expansion across major healthcare regions.

The US Vascular Graft Market continues to grow steadily as cardiovascular procedures rise by more than 28% and endovascular repair adoption increases above 32%. Hospitals across the country have reported over 35% improvement in long-term graft success rates due to advanced biomaterials. Additionally, more than 25% growth in dialysis patients has strengthened demand for grafts used in arteriovenous access, supporting widespread adoption nationwide.

Key Findings

• Market Size: Global value reached USD 1.16 billion in 2025, USD 1.21 billion in 2026, rising to USD 1.75 billion by 2035 at 4.2%.
• Growth Drivers: Driven by over 30% growth in minimally invasive repairs and more than 40% adoption of advanced synthetic graft materials improving treatment outcomes.
• Trends: Demand grows with above 35% rise in endovascular procedures and 28% increase in biologically enhanced grafts adopted globally.
• Key Players: Getinge Group, Bard, Terumo, W. L. Gore, B. Braun & more.
• Regional Insights: North America holds 36% share driven by over 30% growth in cardiovascular procedures. Europe captures 30% with more than 28% rise in endovascular repairs. Asia-Pacific accounts for 25% supported by above 35% increase in vascular disease cases. Middle East & Africa holds 9% with over 15% expansion in graft adoption.
• Challenges: Over 18% infection risk in synthetic grafts and more than 12% incidence of graft failure restrict broader adoption.
• Industry Impact: More than 40% improvement in clinical outcomes and 30% increase in procedural accuracy reshape surgical standards.
• Recent Developments: New graft technologies improved durability by over 25% and reduced complications by nearly 20% in clinical evaluations.

The Vascular Graft Market is evolving rapidly with innovation in hybrid graft structures, antimicrobial coatings, and custom-fit biomaterials. Over 30% rise in aortic and peripheral repair procedures is influencing the development of specialized graft designs. Technological advances focused on improving patency and reducing complication rates by more than 20% are transforming treatment outcomes. Growing adoption in emerging regions, supported by expanding surgical capacity, continues to enhance global market penetration.

Vascular Graft Market Trends

The Vascular Graft Market is experiencing strong traction as demand accelerates across cardiovascular, endovascular, and hemodialysis applications. Adoption of synthetic grafts continues to rise, accounting for more than 40% of procedural preferences due to improved biocompatibility and durability. Biological grafts, however, are gaining momentum with over 25% usage growth, driven by reduced infection rates and enhanced patency. The shift toward minimally invasive vascular interventions has increased endovascular graft utilization by more than 35%, supported by a nearly 30% rise in peripheral artery disease cases. Hospitals dominate the end-use segment with over 55% of graft procedures performed in these settings, while ambulatory surgical centers are expanding at a pace of more than 20% as patient preference for same-day procedures grows. Hybrid vascular grafts are witnessing over 15% adoption growth, particularly in complex aortic reconstructions. Additionally, product approvals and technological advances such as polymer-reinforced structures, antimicrobial coatings, and customized graft designs are supporting more than 28% improvement in procedural outcomes. Overall, rising cardiovascular complications, clinical advancements, and expanding surgical capabilities are shaping the evolving landscape of the Vascular Graft Market.

Vascular Graft Market Dynamics

OPPORTUNITY

Rising Adoption of Endovascular Repair Procedures

Growth in endovascular interventions is creating strong market opportunities as more than 35% of vascular repair procedures now use minimally invasive graft systems. Over 40% of surgeons prefer advanced stent-graft combinations due to better patient outcomes and lower complication rates. Demand is fueled further by a 30% rise in peripheral artery disease cases and a 25% improvement in graft material enhancements. Combined, these shifts are accelerating the adoption of next-generation vascular grafts across major healthcare settings.

DRIVERS

Increasing Burden of Cardiovascular and Aortic Disorders

Cardiovascular complications continue to intensify the demand for vascular grafts, with more than 50% of graft procedures linked to severe arterial blockages. Incidences of aortic aneurysms have risen above 20%, while bypass procedures have grown by nearly 30%, driving consistent utilization of synthetic and biological grafts. Hospitals report over 45% of patients falling into high-risk categories, strengthening dependence on durable graft materials. Enhanced surgical success rates, exceeding 35%, are further accelerating the clinical preference for advanced graft technologies.

RESTRAINTS

"Increased Incidence of Post-Implant Complications"

Post-implant complications present a significant restraint, affecting both surgical planning and long-term patient outcomes. Infection risks rise by nearly 18% in certain synthetic graft applications, while restenosis and graft failure occur in more than 12% of cases, reducing procedural success rates. Revision surgeries are required in over 10% of complex vascular procedures, limiting wider clinician adoption of high-risk graft types. Additionally, more than 20% of vascular specialists report compatibility challenges in patients with multiple comorbidities, restricting the use of some advanced graft systems.

CHALLENGE

"High Cost and Limited Availability of Advanced Graft Technologies"

Premium vascular grafts remain difficult to access in several regions due to rising procurement costs and distribution constraints. More than 30% of hospitals face challenges sourcing next-generation grafts, leading to disparities in treatment standards. A 25% adoption gap exists between advanced and conventional grafts, particularly in developing markets with limited infrastructure. Supply constraints delay procedures for nearly 15% of patients, while 22% of healthcare facilities report inconsistent delivery cycles. These issues collectively hinder widespread integration of innovative graft technologies.

Segmentation Analysis

The Vascular Graft Market demonstrates a diverse segmentation structure shaped by material innovation and clinical demand across major treatment categories. With the global market valued at USD 1.16 Billion in 2025 and projected to reach USD 1.75 Billion by 2035 at a CAGR of 4.2%, demand is influenced heavily by type-specific performance attributes and application-specific procedural growth. ePTFE, polyester, and PTFE grafts collectively account for more than 70% utilization share due to high durability and biocompatibility. Meanwhile, clinical applications such as cardiovascular disease treatment contribute over 45% of total procedural usage, followed by aneurysm repair and vascular occlusion therapies. Each segment shows distinct adoption patterns supported by procedural volume, graft compatibility, and advancements in vascular reconstruction technologies.

By Type

ePTFE Vascular Graft

ePTFE grafts maintain strong demand due to their enhanced flexibility, low thrombogenicity, and over 35% preference rate among surgeons handling critical bypass procedures. More than 40% of complex vascular reconstructions rely on ePTFE materials owing to high patency performance and reduced infection risks. Adoption is further supported by nearly 30% improvement in procedural outcomes associated with ePTFE configurations.

ePTFE Vascular Graft Market Size revenue in 2025 represented a significant share of the overall market, holding approximately 32% share and advancing at a CAGR of 4.2% based on superior biocompatibility and increased demand across endovascular and open surgical reconstructions.

Polyester Vascular Graft

Polyester grafts remain widely used in aortic and peripheral procedures, driven by over 28% procedural utilization due to their strong structural integrity. With more than 33% of aneurysm repairs depending on polyester grafts, demand continues to expand. High porosity, combined with excellent suture retention, contributes to steady clinical preference.

Polyester Vascular Graft Market Size revenue in 2025 accounted for nearly 29% of the market, progressing with a CAGR of 4.2% as technological refinement and increased usage in large-vessel repairs strengthen segment expansion.

PTFE Vascular Graft

PTFE grafts exhibit strong penetration across dialysis access procedures and peripheral vascular repairs, supported by more than 25% utilization. Their non-reactive structure and reduced permeability drive adoption, while surgeons report over 30% boost in long-term graft stability. This segment benefits significantly from advancements in reinforced PTFE formulations.

PTFE Vascular Graft Market Size revenue in 2025 captured approximately 26% share, with a consistent CAGR of 4.2%, reinforced by rising dialysis access procedures and wider acceptance in chronic vascular disease management.

Others

The "Others" category includes biological grafts, hybrid composites, and novel polymers, collectively expanding with more than 18% utilization growth. These grafts show increased adoption in complex reconstructions due to enhanced tissue integration and over 20% reduction in postoperative complications. Hybrid grafts, in particular, are gaining traction for challenging aortic segments.

Others Market Size revenue in 2025 represented about 13% share, growing at a CAGR of 4.2%, driven by clinical preference for improved compatibility and innovation in next-generation graft materials.

By Application

Cardiovascular Diseases

Cardiovascular disease applications dominate graft usage, contributing over 45% of total procedural demand. Increasing arterial blockages and rising bypass surgeries—surpassing 30% growth—sustain adoption. Surgeons report over 35% improvement in patient outcomes when using advanced graft materials, making this application a key growth generator.

Cardiovascular Diseases Market Size revenue in 2025 constituted the largest share at approximately 46%, expanding at a CAGR of 4.2% as procedural volumes grow and treatment complexity rises globally.

Aneurysm

Aneurysm repair applications maintain strong traction, representing more than 30% procedural usage. Endovascular aneurysm repair (EVAR) procedures have increased by over 25%, promoting the use of specialized grafts for aortic stabilization. Enhanced durability and over 20% reduction in rupture risk support the expansion of this application segment.

Aneurysm Market Size revenue in 2025 held around 31% share, growing steadily at a CAGR of 4.2%, supported by broadening adoption of endovascular grafting solutions.

Vascular Occlusion

Vascular occlusion procedures require reliable grafts to restore blood flow, accounting for more than 18% of total applications. Increased prevalence of occlusive diseases—rising above 22%—reinforces demand for PTFE and ePTFE grafts. Clinical reports show a 28% improvement in long-term patency rates, strengthening the segment's significance.

Vascular Occlusion Market Size revenue in 2025 represented about 18% share, projected to grow at a CAGR of 4.2% driven by higher procedural needs and better clinical outcomes.

Others

The “Others” segment covers trauma, congenital vascular defects, and specialized surgical reconstructions, contributing nearly 10% of total usage. Adoption is rising with more than 15% procedural growth as complex interventions require advanced graft solutions. Greater focus on hybrid and biological grafts enhances performance in unique surgical scenarios.

Others Application Market Size revenue in 2025 accounted for close to 10% share, with a stable CAGR of 4.2%, shaped by the increasing demand for customized vascular reconstruction approaches.

Vascular Graft Market Regional Outlook

The Vascular Graft Market demonstrates strong regional variation in demand and technological adoption, supported by rising cardiovascular cases and increasing preference for advanced graft materials. With the Global Vascular Graft Market valued at USD 1.16 Billion in 2025 and projected to reach USD 1.21 Billion in 2026 and USD 1.75 Billion by 2035, regional contributions are distributed across four major markets. North America holds 36% share, Europe accounts for 30%, Asia-Pacific contributes 25%, while Middle East & Africa represents 9% of the total global market. Differences in market size across regions reflect variations in treatment volumes, healthcare infrastructure, and graft technology adoption.

North America

North America continues to lead the market, driven by more than 30% rise in cardiovascular surgical procedures and above 40% utilization of synthetic grafts. The region has also observed a 28% increase in endovascular repairs and more than 22% growth in dialysis-related graft use. Advancements in stent-graft systems and strong hospital infrastructure further strengthen adoption across the US and Canada. Growing preference for minimally invasive procedures, rising vascular disease incidences, and improved graft performance—enhanced by over 35%—contribute to consistent regional expansion.

North America held a 36% share of the global market, with an estimated USD 0.42 Billion market size in 2025. The region is expected to expand steadily, supported by increasing procedural volumes and rapid integration of next-generation vascular graft technologies.

Europe

Europe demonstrates strong market presence, supported by more than 25% increase in aneurysm screening programs and over 30% growth in endovascular graft procedures across major countries. Surgeons report a 35% improvement in graft longevity due to advanced materials, contributing to higher adoption. Rising peripheral artery disease cases—up by 26%—and broader availability of specialized graft configurations further strengthen regional usage. Enhanced patient access to vascular interventions across Germany, France, and the UK continues to support consistent market expansion.

Europe accounted for 30% share of the global market, translating to approximately USD 0.35 Billion in 2025. Market growth is fueled by strong clinical infrastructure and increasing emphasis on improved vascular repair outcomes.

Asia-Pacific

Asia-Pacific witnesses rapid progression, driven by more than 35% surge in cardiovascular disease prevalence and a 28% increase in endovascular surgical procedures. Expanding healthcare capacity in China, India, and Japan has enabled wider adoption of PTFE, ePTFE, and polyester grafts. More than 25% increase in dialysis patient volume is boosting demand for arteriovenous access grafts. Hospitals across emerging markets report nearly 20% improvement in procedural outcomes due to improved access to advanced graft technologies, supporting accelerated market penetration.

Asia-Pacific represented 25% share of the global market, equating to nearly USD 0.29 Billion in 2025. The region continues to grow, supported by rising treatment demand and expanding vascular surgery capabilities.

Middle East & Africa

The Middle East & Africa region is experiencing gradual yet increasing adoption, driven by over 20% rise in cardiovascular and aneurysm-related conditions. GCC countries report nearly 18% growth in procurement of synthetic grafts as hospital modernization accelerates. Dialysis-related graft usage has increased by more than 15%, supported by expanding renal care facilities. Additionally, hybrid and biological grafts have gained nearly 10% traction as specialist training expands and surgical capabilities improve. Despite infrastructural disparities, the region is steadily integrating advanced graft technologies.

Middle East & Africa held 9% share of the global market, amounting to about USD 0.10 Billion in 2025. Growth is supported by improving healthcare infrastructure, rising vascular disease cases, and increasing availability of advanced graft materials across major nations.

List of Key Vascular Graft Market Companies Profiled

Investment Analysis and Opportunities in Vascular Graft Market

The vascular graft market offers expanding investment potential as global demand increases by more than 25% across cardiovascular and endovascular interventions. More than 40% of medical facilities worldwide have upgraded to next-generation graft technologies, driving opportunities for material innovation and minimally invasive applications. Over 35% of surgeons report improved outcomes using antimicrobial and hybrid graft designs, encouraging investors to focus on R&D and manufacturing scalability. With more than 30% procedural growth expected in emerging markets, investments in distribution expansion, localized production, and customized clinical solutions present high-value opportunities. Technological advancements contributing to nearly 28% enhancement in graft durability further strengthen the long-term investment landscape.

New Products Development

New product development in the vascular graft market is accelerating, driven by more than 32% increase in demand for advanced biomaterials and hybrid graft solutions. Manufacturers are focusing on structural reinforcement technologies that improve graft performance by over 25%. Antimicrobial-coated grafts have gained nearly 20% adoption due to reduced infection risk, while personalized graft configurations have risen by almost 18% owing to surgeon preference for precision-fit implants. Development of next-gen low-porosity grafts, which improve patency by more than 30%, continues to attract strong clinical interest. This expanding innovation ecosystem creates significant competitive advantages for companies advancing vascular biomaterial engineering.

Recent Developments

• Getinge Group: Launched an upgraded synthetic graft platform introducing more than 22% improvement in tensile strength and enhanced porosity control, supporting wider adoption in high-risk arterial reconstructions.
• Terumo: Introduced a new hybrid graft for minimally invasive procedures with over 28% better flexibility and 20% reduction in post-operative complications based on clinical evaluations.
• W. L. Gore: Expanded its vascular graft portfolio with a low-profile endovascular graft delivering nearly 30% higher deployment accuracy and improved anatomical compatibility in complex aneurysm repairs.
• B. Braun: Developed an antimicrobial coated graft demonstrating more than 18% reduction in infection cases and over 15% improvement in early graft integration performance.
• LeMaitre: Released a next-generation biologic graft offering 25% better tissue integration and nearly 17% lower restenosis incidence in long-term follow-ups.

Report Coverage

The vascular graft market report provides extensive insights into product performance, end-use adoption trends, and competitive dynamics across global regions. It includes detailed SWOT analysis to evaluate market strengths, weaknesses, opportunities, and threats. Key strengths identified include over 40% adoption of synthetic grafts driven by material durability, and more than 30% improvement in surgical outcomes linked to advanced hybrid grafts. Weaknesses include nearly 12% incidence of graft failure in complex cases and 18% infection-related complications in certain synthetic graft types. Opportunities are supported by more than 25% growth in minimally invasive surgeries and over 35% surgeon preference for next-generation graft materials. Threats include increasing procedure costs, with more than 20% of hospitals reporting procurement challenges, and nearly 15% supply inconsistency in emerging markets. The report covers regional market shifts, company profiles, product innovations, material performance metrics, and competitive benchmarking, offering a comprehensive assessment of the global vascular graft sector for strategic decision-making and market positioning.